FDA Inspection 1215303 — Northwell Health IRB
The FDA completed an inspection of Northwell Health IRB on July 20, 2023 in Manhasset, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 20, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Manhasset, NY (United States)
Additional Details
IRB